This content is PDF only. Please click on the PDF icon to access.
The Boston Collaborative Drug Surveillance Program (BCDSP) was established in 1966 to study prospectively the clinical efficacy and toxicity of drugs used on medical wards in several cooperating hospitals in the U.S. and abroad. Data have now been recorded on more than 20 000 medical admissions involving over 200 000 drug orders, and this volume summarizes much of it. The BCDSP is the first comprehensive program designed to assess drug effects in medical patients under typical conditions of clinical use. Such information can only be obtained by monitoring in depth large numbers of patients under carefully controlled conditions. Neither initial
Drug Effects in Hospitalized Patients.. Ann Intern Med. ;86:513–514. doi: 10.7326/0003-4819-86-4-513_2
Download citation file:
Published: Ann Intern Med. 1977;86(4):513-514.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use